Group 1 - Digital finance is a crucial component of the digital economy, which provides the necessary conditions for its development [1] - The digital economy is characterized by the extensive application of digital technologies, leading to industrial transformation and resource optimization [1][2] - The digital economy encompasses both digital industrialization and industrial digitization, forming the foundation for the development of digital finance [2] Group 2 - Digital industrialization refers to economic activities that rely on digital technologies and data elements, with significant advancements in new infrastructure such as 5G and AI [2] - The hardware manufacturing capabilities and innovation in sectors like chips and integrated circuits are continuously improving, enhancing the integration of manufacturing and digitalization [2] - The data industry is growing, with a focus on data mining, collection, storage, and analysis, which empowers various sectors and drives the development of digital finance [2] Group 3 - Industrial digitization involves the application of digital technologies in traditional industries, leading to increased production efficiency and output [3] - The process of industrial digitization can be divided into four stages: infrastructure development, individual applications, comprehensive integration, and collaborative innovation [3] - New financial service models such as digital payments and mobile banking are emerging, rapidly expanding the market size and transforming financial activities for businesses and individuals [3] Group 4 - The digital transformation across all sectors is fundamental to the development of digital finance, acting as a significant engine for global economic growth [4] - The global digital transformation has progressed through three phases, with the current phase characterized by "intelligent" and "platform-based" features [4] - The role of internet companies and traditional manufacturers in driving digital transformation is becoming increasingly prominent [4] Group 5 - The World Bank reports that global digital transformation is accelerating, significantly impacting communication, information access, and business activities [5][6] - From 2000 to 2022, the growth rate of the information technology services industry was nearly double that of the global economy, with a 7% annual growth rate in digital services employment [5] - The digital industry not only contributes to growth and job creation but also has positive spillover effects across various sectors [6] Group 6 - The digital divide is widening, particularly in low- and middle-income countries, where disparities in internet speed and access hinder digital benefits [6] - China's digital transformation has achieved remarkable success under the digital economy strategy, creating unique competitive advantages [6] - These advantages, including advanced infrastructure and extensive data resources, lay a solid foundation for the development of digital finance [6] Group 7 - The book on digital finance, led by experts, aims to provide a comprehensive overview of the development of digital finance in China, covering theoretical and practical aspects [8] - It introduces the concept of digital financial infrastructure and analyzes its current state and key development directions [8] - The book also proposes new ideas and measures to balance innovation and regulation in digital finance, enhancing international competitiveness [8]

近日，中国证监会国际合作司发布《关于溜溜果园集团股份有限公司境外发行上市及境内未上市股 份"全流通"备案通知书》。当中显示：证监会对溜溜果园集团股份有限公司备案事项通知如下： 三、自本备案通知书出具之日起至本次境外发行上市结束前，溜溜果园如发生重大事项，应根据境内企 业境外发行上市有关规定，通过中国证监会备案管理信息系统报告。 四、溜溜果园完成境外发行上市后15个工作日内，应通过中国证监会备案管理信息系统报告发行上市情 况。溜溜果园在境外发行上市和股份转换过程中应严格遵守境内外有关法律、法规和规则。 五、溜溜果园自本备案通知书出具之日起12个月内未完成境外发行上市及股份转换，拟继续推进的，应 当更新备案材料。 一、溜溜果园拟发行不超过19,362,400股境外上市普通股并在香港联合交易所上市。 二、溜溜果园10名股东拟将所持合计67,347,108股境内未上市股份转为境外上市股份，并在香港联合交 易所上市流通。 ...

Core Viewpoint - The market showed strong performance in the morning session, with the Shanghai Composite Index recovering the 3900-point mark and the ChiNext Index rising over 2% at one point [1] Market Performance - The total trading volume in the Shanghai and Shenzhen markets reached 1.19 trillion yuan, an increase of 97.7 billion yuan compared to the previous trading day [1] - Nearly 3500 stocks in the market experienced gains [1] Sector Highlights - The Hainan Free Trade Zone concept stocks saw a collective surge, with companies like Hainan Airlines and Hainan Ruize hitting the daily limit [1] - The commercial aerospace sector showed repeated strength, with stocks such as Shenjian Co. and Beidou Xingtong reaching the daily limit [1] - The computing hardware sector was active, with the "Yizhongtian" optical module trio all rising [1] - Semiconductor equipment stocks rallied, with companies like Tuojing Technology reaching historical highs [1] Declining Sectors - The AI medical concept experienced fluctuations, with Huaren Health seeing a significant drop [1] - Sectors with notable declines included pharmaceuticals, film and television, and banking [1] Closing Summary - At the close, the Shanghai Composite Index rose by 0.64%, the Shenzhen Component Index increased by 1.36%, and the ChiNext Index gained 1.8% [1]

Core Viewpoint - The duty-free shopping policy in Hainan Free Trade Port is continuously releasing benefits, driving a new wave of consumption in the market [1] Group 1: Sales Performance - On December 18, the first day of the closure, Sanya's total duty-free sales reached 118 million yuan [1] - On December 19, Sanya's duty-free stores achieved a single-day sales of 105 million yuan, representing a year-on-year increase of 45.8% [1] - On December 20, the total sales in duty-free stores reached 108 million yuan, with a year-on-year growth of 47% [1] - Sanya's duty-free consumption has exceeded 100 million yuan for three consecutive days [1]

Core Viewpoint - Shanghai Hengrun Da Biological Technology Co., Ltd. has announced a commercialization partnership with China Resources Double Crane Pharmaceutical Co., Ltd. for the Renikiorunase Injection (Hengkailai), granting exclusive national agency rights to China Resources Double Crane [1] Group 1: Company Overview - Hengrun Da is the first company in China to independently develop a CD19 CAR-T product targeting relapsed or refractory large B-cell lymphoma (r/r LBCL) [1] - China Resources Double Crane's acquisition of exclusive rights reflects its commitment to social responsibility and innovation in the biopharmaceutical sector [1] Group 2: Industry Implications - This collaboration represents a new exploration of collaborative development models in the field of tumor immunotherapy in China [1] - The partnership emphasizes the focus on clinical needs and the mission of innovation in therapeutic solutions within the biopharmaceutical industry [1]

据Wind数据，截至发稿，以股权登记日计算，今年以来A股上市公司现金分红总额达到2.61万亿元，创 出历史新高。 Wind数据显示，今年以来，A股上市公司迈瑞医疗、三七互娱、御银股份和玲珑轮胎分红次数均为三 次。山东路桥、雅戈尔、深圳华强、奕帆传动、陕国投A、鱼跃医疗、行动教育、南山铝业、隆扬电 子、艾融软件、分众传媒、药明康德、百龙创园、吉比特、华宝股份、新坐标、龙佰集团、远翔新材、 华明装备、卓创资讯、九强生物、金帝股份、开普检测、西部证券、海希通讯、开能健康、金能科技、 金岭矿业、国光股份和吉电股份分红次数均为两次。 自2022年底中央经济工作会议首次将"红利纳入资本市场改革方向"以来，监管层围绕上市公司现金分红 持续发力，政策密度和执行强度显著增强。申万宏源分析师杨俊文表示，分红政策体系已从倡导层面进 入刚性落实阶段，不仅提升了高股息资产的确定性，也显著强化了高分红策略的因子有效性与选股基 础。 回顾近期的市场行情，在无风险利率持续走低的环境下，权益资产吸引力明显。"头部公司的引领示范 清晰地向市场传递了一个积极信号——国内核心资产具备为投资者提供持续、稳定现金回报的能力，价 值投资的压舱石作用愈发凸 ...

本次所融资金将用于显微手术器械智能制造中心的建设，眼科智能设备和耗材项目落地及海外市场销售 拓展。碧利医疗成立于2017年，专注于二、三类眼科、耳鼻喉科等全系列显微手术器械套包研发生产与 销售。创始团队曾是全球眼科显微手术器械领导品牌在国内唯一的OEM合作伙伴。 近日，国内眼科显微手术器械领域领导品牌—苏州碧利医疗科技有限公司（以下简称"碧利医疗"）完成 新一轮数千万元的融资。本轮融资由普华资本领投，深岩创投跟投，熙桥资本担任独家财务顾问。 ...

会上，翔宇医疗与江苏医药职业学院"翔宇产业学院"揭牌仪式顺利举行。双方将以产业学院为载体，整 合教学与产业资源，构建协同培养模式，既破解当前康复行业"产教脱节、人才供需错配"的痛点，也为 智能康复技术转化与应用提供人才支撑。 12月19-20日，以"数智赋能、融合创新"为主题的康复产教发展论坛暨全国康复行业产教融合共同体第 一届理事会第三次会议在江苏医药职业学院召开。 ...

近日，石药集团发布公告称，自2025年12月19日起，董事会进行了高层人事调整。 (编辑：杨燕 林辰) 张翠龙因工作调动不再担任副主席、首席执行官及授权代表，但仍将继续担任执行董事。蔡磊获委任为 副主席、执行董事、首席执行官及授权代表，魏青杰获委任为副主席、执行董事及首席运营官。 （石药集团公告） 蔡磊现年45岁，自2014年4月加入公司，现任执行总裁及多个部门负责人，持有4万股公司股份，年薪为 1.7万美元及每年6.3万港元的董事袍金。蔡磊是石药集团董事会主席、执行董事及主要股东蔡东晨之 子，也是执行董事蔡鑫的胞兄。 魏青杰现年56岁，自2019年5月加入公司，担任多个重要职务，持有30万股公司股份及140万股尚未归属 的股份奖励，月薪为6万元及每年6.3万港元的董事袍金。 ...

近日，加科思发布公告称，公司与阿斯利康就泛KRAS抑制剂JAB-23E73订立许可及合作协议。 董事会认为，此协议符合公司及股东的整体最佳利益，有助于进一步加强全球合作网络，最大化公司技 术平台的科学及商业价值。 （加科思公告） (编辑：杨燕 林辰) 根据协议，北京加科思（公司非全资附属公司）有权从阿斯利康收取1亿美元的首付款，并在达到若干 开发、监管及商业里程碑后有资格获得额外潜在总对价最高可达19.15亿美元的里程碑付款。此外，在 许可产品成功商业化后，北京加科思将获得基于许可产品净销售额计算的分层特许权使用费。 公告显示，阿斯利康将获得独家许可在全球范围内（除中国（不包括香港、澳门及台湾）外）研究、开 发、注册、制造及商业化JAB-23E73。北京加科思需向阿斯利康提供必要的技术转移、数据及合理协 助。阿斯利康负责其区域内的开发、监管事务及商业化相关主要活动及费用，而在中国的活动及成本将 由双方共同承担。 ...